Anita et al. also verified that the genetic alterations of YTHDF3 were frequently associated with poor prognosis in BC patients, suggesting their transcripts upregulation might promote BC progression via a m6A-dependent manner [23]. The gene discussed is YTHDF3; the disease is breast cancer.